Related Experiment Video
Updated: Mar 30, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future
Timothy M Hughes1, Kaycee M Sink2
1Department of Internal Medicine, Division of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Insights
High blood pressure, particularly in midlife, is linked to cognitive decline and dementia. While observational studies suggest hypertension treatment may prevent dementia, clinical trials show mixed results, necessitating further research with biomarkers.
Area of Science:
- Neurology
- Cardiology
- Gerontology
Background:
- Elevated blood pressure, especially midlife hypertension, is associated with cognitive decline and dementia.
- Hypertension impacts brain structure, contributing to small vessel disease and vascular dementia.
- Hypertension interacts with Alzheimer's pathology, potentially lowering the threshold for symptom manifestation.
Purpose of the Study:
- To review evidence on blood pressure, dementia biomarkers, and cognitive health.
- To highlight challenges in randomized trials of hypertension and cognition.
- To propose future research directions for understanding hypertension's role in cognitive decline.
Main Methods:
- Review of observational studies linking blood pressure to cognitive decline and dementia.
- Analysis of studies on hypertension's effects on brain structure and small vessel disease.
- Examination of randomized trials of antihypertensive therapy with cognitive endpoints.
Main Results:
- Observational data strongly suggest elevated blood pressure is linked to cognitive decline and dementia.
- Hypertension is associated with brain changes like small vessel disease and Alzheimer's biomarkers (beta-amyloid, tau).
- Randomized trials of antihypertensive therapy have not consistently supported cognitive benefits.
Conclusions:
- Despite strong biological plausibility, randomized trials do not fully support observational findings on hypertension treatment for cognitive benefits.
- Future trials should incorporate dementia biomarkers and assess genetic/cardiometabolic risk factors.
- Further research is needed to reconcile observational and trial data for effective hypertension management in cognitive health.
Abstract:
This review summarizes evidence from studies of blood pressure and dementia-related biomarkers into our understanding of cognitive health and highlights the challenges facing studies, particularly randomized trials, of hypertension and cognition. Several lines of research suggest that elevated blood pressure, especially at midlife, is associated with cognitive decline and dementia and that treatment of hypertension could prevent these conditions. Further, studies of hypertension and brain structure show that blood pressure is associated with several forms of small vessel disease that can result in vascular dementia or interact with Alzheimer's pathology to lower the pathologic threshold at which Alzheimer's signs and symptoms manifest. In addition, recent studies of hypertension and Alzheimer's biomarkers show that elevated blood pressure and pulse pressure are associated with the extent of brain beta amyloid (Aβ) deposition and altered cerebral spinal fluid profiles of Aβ and tau indicative of Alzheimer's pathology. However, in spite of strong evidence of biological mechanisms, results from randomized trials of antihypertensive therapy for the prevention of cardiovascular or cerebrovascular disease that include cognitive endpoints do not strongly support the observational evidence that treatment of hypertension should be better for cognition. We propose that future clinical trials should consider including dementia biomarkers and assess genetic and cardiometabolic risk factors that have been associated with progression of the underlying disease pathology to help bridge these gaps.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications

